Femasys Inc is a biomedical company based in Suwanee, GA, dedicated to addressing the unmet needs of women worldwide through the development of innovative reproductive health technologies. Their portfolio includes minimally invasive, in-office solutions for permanent birth control and infertility, aiming to provide non-surgical options for women seeking reproductive health solutions.
With a focus on meeting the needs of women underserved by current options, Femasys Inc offers a range of clinical-stage and commercial assets, including FemaSeed, a FDA-cleared first-line infertility treatment, and diagnostic tools like FemVue, FemCath, and FemCerv for evaluating the fallopian tubes and cervical cancer. Through their superior innovation, Femasys Inc aims to empower women and revolutionize the field of reproductive health.
Generated from the website